Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

181 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • CTT Research Gilbert, Arizona, United States
  • Ctr for Dermatology Clinical Res Fremont, California, United States
  • USC Keck School of Medicine Los Angeles, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

NCT06799000

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Cheryl Effron MD Inc Anaheim, California, United States
View all 139 locations
View Trial Details
Active, not recruiting

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610

Conditions
Acne Vulgaris, Acneiform Eruptions, Bacterial Infections, +13 more
Locations
  • Medical Dermatology Specialists (Phoenix) Phoenix, Arizona, United States
  • First OC Dermatology Research, Inc. Irvine, California, United States
  • Wallace Medical Group, Inc. Los Angeles, California, United States
  • Northridge Clinical Trials Northridge, California, United States
View all 61 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Safety of Colchicine

NCT05335148

Conditions
Dermatitis, Radiation Therapy, Skin Diseases, +1 more
Locations
  • RWJBarnabas Health - Cooperman Barnabas Livingston, New Jersey, United States
  • Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States
  • Rutgers, The State University of New Jersey Board Contact: New Brunswick, New Jersey, United States
View Trial Details
Active, not recruiting

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT06018428

Conditions
Alopecia, Alopecia Areata, Dermatitis, +6 more
Locations
  • Scottsdale, Arizona Scottsdale, Arizona, United States
  • Fayetteville, Arkansas Fayetteville, Arkansas, United States
  • Hot Springs, Arkansas Hot Springs, Arkansas, United States
  • Encinitas, California Encinitas, California, United States
View all 33 locations
View Trial Details
Active, not recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT06526182

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital del Mar - Parc de Salut Mar Barcelona, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Consorci Hospital General Universitari de València Valencia, Spain
View Trial Details
Active, not recruiting

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT07011706

Conditions
AD, Atopic, Atopic Dermatitis, +12 more
Locations
  • Aclaris Clinical Site Phoenix, Arizona, United States
  • Aclaris Clinical Site Tucson, Arizona, United States
  • Aclaris Study Site Bryant, Arkansas, United States
  • Aclaris Clinical Site Beverly Hills, California, United States
View all 60 locations
View Trial Details
Active, not recruiting

Seal, Stopping Eczema and Allergy Study

NCT03742414

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Sean N. Parker Center for Allergy & Asthma Research at Stanford University Palo Alto, California, United States
  • Division of Pediatric Allergy and Clinical Immunology, National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions